| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 3.87 | 0.79 | 1.45 | 5.63 | 6.81 | 14.08 | 9.16 |
| Depreciation & Amort ($Mil): | 1.61 | 1.61 | 2.12 | 1.72 | 1.75 | 1.65 | 1.47 |
| Operating Income ($Mil): | -28.35 | -36.50 | -36.76 | -24.72 | -15.91 | -9.21 | -10.22 |
| Net Income ($Mil): | -34.18 | -28.67 | -25.44 | -26.53 | -2.09 | -13.00 | -13.00 |
| Earnings Per Share ($): | -1.35 | -1.25 | -1.53 | -1.80 | N/C | N/C | N/C |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 8.07 | 12.23 | 13.97 | 17.54 | 15.64 | 16.91 | 28.21 |
| Current Liabilities ($Mil): | 7.32 | 8.07 | 6.58 | 7.08 | 3.26 | 4.48 | 2.91 |
| Long Term Debt ($Mil): | 0.12 | 0.23 | 1.15 | 1.55 | 1.12 | 1.15 | 0.77 |
| Shares Outstanding (000): | 26100 | 24040 | 18720 | 15250 | 0 | 0 | 0 |
| Common Equity ($Mil): | -12.19 | -9.40 | -10.81 | -6.22 | 12.83 | 14.90 | 25.99 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -883.20 | -3629.11 | -1754.48 | -471.23 | -30.69 | -65.91 | -141.92 |
| Return on Equity (%): | 0.00 | 305.00 | 235.34 | 426.53 | -16.29 | -62.28 | -50.02 |
| Return on Assets (%): | -181 | -133.35 | -102.33 | -94.21 | -8.21 | -33.05 | -33.07 |
| P/E Ratio: | 0 | -4.56 | -4.21 | -4.51 | 0.00 | 0.00 | 0.00 |
| Price/Book: | 0 | -14.58 | -11.15 | -19.91 | 0.00 | 0.00 | 0.00 |
| Debt Equity: | -0.01 | -0.02 | -0.11 | -0.25 | 0.09 | 0.08 | 0.03 |
| Interest Coverage: | 0.00 | -190.13 | -132.89 | -203.08 | -11.29 | -308.33 | -49.00 |
| Book Value ($): | -0.47 | -0.39 | -0.58 | -0.41 | 0.00 | 0.00 | 0.00 |
| Price/Sales: | 179.23 | 14.43 | 83.14 | 21.99 | 0.00 | 0.00 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN INC. | +9.10 | 56.09 | |
| GILEAD SCIENCES | -1.80 | 45.91 | |
| CELGENE CORPORA | -8.00 | 58.56 | |
| BIOGEN IDEC INC | -31.90 | 43.13 | |
| STEMCELLS INC. | -56.40 | 1.23 |
